Positron, a medical technology company, has won the Innovation Award in the PET-CT Imaging category in the 2025 Medical Device Network Excellence Awards for making a substantial impact on the evolution of hybrid imaging technology. The company’s latest PET-CT systems have introduced significant advancements in affordability, workflow, and clinical application.
The Medical Device Network Excellence Awards honor the most significant achievements and innovations in the global medical devices industry. Powered by GlobalData’s business intelligence, the Awards recognize the people and companies leading positive change and shaping the future of the industry.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Positron won the award for making hybrid imaging more accessible, efficient, and clinically versatile for healthcare providers.
Expanding access through affordability and compact design
One of the most persistent challenges in the adoption of PET-CT imaging has been the high cost and substantial space requirements of traditional systems. Positron has addressed these barriers by developing PET-CT solutions that are economically accessible and physically adaptable to a wider range of healthcare environments. Positron’s PET-CT 64 Slice stands out as the most cost-effective PET-CT system currently available in the US, offering a lower price point that enables smaller clinics and community hospitals to consider advanced hybrid imaging for the first time.
The affordability is further supported by flexible rental and service options, which reduce the need for significant upfront investment. Positron offers all-inclusive rental packages, which cover not only the scanner but also clinical, technical, and training services, making it feasible for facilities with limited capital resources to implement PET-CT technology.
In addition to cost, space constraints have historically limited PET-CT adoption. Positron’s systems feature the smallest industry footprint, requiring a room size of just 26 x 14 feet. This compact design allows installation in facilities where larger systems would be impractical, such as outpatient imaging centers or smaller hospitals. The ergonomic gantry, wide 72cm aperture, and real-time status displays further enhance both patient comfort and technologist workflow, making the system adaptable to a variety of clinical settings.
Driving workflow efficiency and operational performance
Operational efficiency is a critical factor for imaging providers, especially as patient volumes increase and healthcare systems seek to maximize throughput without sacrificing quality. Positron’s PET-CT systems are engineered to streamline workflow at every stage of the imaging process. The integration of CT attenuation correction, for instance, not only improves image quality but also accelerates scan times, enabling facilities to perform up to 20 or more exams per day – substantially higher than the throughput of standalone PET systems.
Automated features play a significant role in this efficiency. Positron’s PET-CT incorporates intelligent, self-shielded quality control that can be completed with a single button in just five minutes, minimizing downtime and reducing the risk of human error. Real-time technologist guidance, delivered via an intuitive visualization engine, supports staff throughout each study, ensuring consistent results and reducing the learning curve for new users.
Additional workflow enhancements include seamless integration with third-party quantification software, such as those used for coronary flow reserve (CFR) analysis, and a streamlined patient registration assistant that simplifies data entry and review. These features collectively reduce administrative burden, support high system uptime (reported at 99%), and enable facilities to deliver timely, reliable diagnostics to a larger patient population.
Enhancing clinical versatility and diagnostic confidence
Modern healthcare increasingly demands imaging platforms that can address a broad spectrum of clinical needs. Positron’s PET-CT systems are designed to support advanced cardiac, oncology, and neurology imaging within a single, versatile platform. Positron’s PET-CT is optimized for myocardial perfusion imaging — a critical tool in the assessment of coronary artery disease and microvascular dysfunction — but also offers high sensitivity and specificity for tumor detection and neurological evaluation.
The system’s advanced detector technology, including digital signal processing and patented light-guided core modules, ensures high-resolution imaging across a wide range of applications. Features such as 4D gating eliminate blurring from cyclical movement, enabling precise alignment of PET and CT images for both attenuation correction and image fusion. The extended field of view and high photon load resistance further support imaging of larger or more complex patients.
Intelligent automation extends to clinical accuracy as well. AI-driven motion correction automatically alerts technologists to patient movement, allowing for immediate intervention and reducing the likelihood of suboptimal scans. Device-free respiratory gating and proprietary reconstruction algorithms enable high-quality images from low-count studies, supporting both patient safety and diagnostic reliability by minimizing radiation exposure and tracer dose.
Positron’s commitment to ongoing innovation is evident in its development pipeline. The forthcoming Affinity 4D PET-CT system, expected to be launched in Q4 2025, will introduce further advances such as LYSO crystal technology for enhanced image clarity, AI-enhanced motion monitoring, and advanced dose reduction techniques. This sustained focus on product development ensures that Positron’s systems remain responsive to evolving clinical requirements and continue to set new standards in hybrid imaging.
“Positron aims to be the key driver shaping the future of PET-CT technology. Our commitment is to expand the PET modality across both cardiac and oncology fields, delivering innovative imaging systems and robust clinical services that empower practices with the most cost-effective solutions in the industry. As the market shifts from SPECT to PET-CT, Positron is not only leading this transformation in nuclear cardiology but also positioning to enter oncology, where we will play a central role in advancing molecular imaging in North America and abroad.“
– Adel Abdullah, President of Positron Corporation
“Positron’s unmatched combination of technology, service, and economics offers practices the best value and a clear path to long-term sustainability and growth”, added Abdullah.
Company Profile
Positron Corporation is a medical technology company that co-develops, manufactures, and sells state-of-the-art PET and PET-CT imaging systems, and clinical services to nuclear medicine healthcare providers throughout North America.
Positron specializes in the field of cardiac Positron Emission Tomography (PET) imaging, the gold standard in cardiac diagnostics. Positron’s innovative PET/PET-CT technologies, clinical services, and practice solutions enable healthcare providers to accurately diagnose coronary artery disease and improve patient outcomes while practicing cost-effective medicine.
Positron’s PET and PET-CT imaging systems and distinct market position are substantial advantages unique to Positron that will facilitate the adoption of cardiac PET and the growth of the nuclear imaging market. Positron will soon offer a state-of-the-art PET-CT 4D molecular imaging device. Positron’s PET- CT(s) will enable nuclear cardiologists to utilize the full capabilities of molecular imaging and nuclear medicine. Positron’s PET-CT systems will also enable the Company to fully service and meet the demands of the vast oncology imaging segment of nuclear medicine.
Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its co-developer, supplier, and R&D venture with Shenyang Intelligent Neuclear Technology Co., a subsidiary of Neusoft Medical Systems.
Please visit the Company’s website at: www.positron.com
Links
Website: https://www.positron.com/
